Sanofi CEO on using AI to support drug trials

Novartis CEO discusses how AI will impact drug developmentПодробнее

Sanofi – Nature’s Building Blocks: Finding Hope in Inclusive Clinical TrialsПодробнее

Sanofi CEO Paul Hudson Talks AI for BioPharma | Bloomberg TalksПодробнее

How AI Is Accelerating Drug DiscoveryПодробнее

Sanofi – Paul Hudson (CEO) introduces Sanofi’s Code of ConductПодробнее

Sanofi – Partner Spotlight: Owkin and Sanofi Embrace the “Golden Era” of Precision Medicine with AIПодробнее

Sanofi chief on new partnership with OpenAI for AI-driven drug developmentПодробнее

Sanofi CEO on AI's Impact, Lung Disease Drug ClearanceПодробнее

CEO Paul Hudson on Sanofi’s Bold New Strategy and “Snackable AI”Подробнее

What's the 'New Sanofi' Like? Let CEO Paul Hudson Explain. | At Barron'sПодробнее

Sanofi CEO Paul Hudson on the coronavirus, the FDA, drug development and moreПодробнее

Sanofi – Dermatologist vs. AI: Future of AI and Atopic DermatitisПодробнее

Sanofi – Biologics x AI Moonshot (BioAIM) ProgramПодробнее

Sanofi CEO on breakthroughs in cancer research, COVID-19 vaccine development, and drug pricingПодробнее

Sanofi – Building a Diverse Early Oncology PipelineПодробнее

Sanofi – Paul Hudson (Directeur Général) présente la Code de Conduite de SanofiПодробнее

Sanofi CEO Paul Hudson on R&D Day: We're going to be the world's leading immunology companyПодробнее

Sanofi – A Million Conversations: Rebuilding Trust in HealthcareПодробнее

Sanofi CEO: Dupixent eczema drug is game-changing for the companyПодробнее